TCI Target Capital Inc

CALGARY, April 19, 2018 /CNW/ - Target Capital Inc. d.b.a. CBi² Capital ("CBi²") (TSXV: TCI) (CSE: TCI) is pleased to announce that it has entered into a strategic alliance agreement with MMJ PhytoTech Limited ("MMJ") (ASX: MMJ) an Australia-based investment company that provides capital and expertise to high growth, early-stage companies in the global cannabis industry (the "Alliance"). Pursuant to the Alliance, CBi² and MMJ will share information and collaborate with each other on co-investment opportunities.

Sonny Mottahed, CBi²'s Chairman, CEO and President commented, "We are excited by the prospect of co-investing with MMJ. The Alliance provides each of us with a broader network from which to access mutually beneficial investment opportunities in both the Northern and Southern hemispheres."

Jason Conroy, MMJ's CEO said, "We are excited by the opportunity to work alongside CBi² and look forward to discussing potential co-investments with them. CBi²'s investment criteria and focus is directly aligned with MMJ's strategic intent to own and build a diversified global cannabis investment portfolio."

About MMJ

MMJ PhytoTech Limited is a global cannabis investment company listed on the Australian Stock Exchange. MMJ focuses on the identification of a number of independent strategic investment opportunities that have the potential to deliver significant shareholder value.

Please visit www.mmjphytotech.com.au for further information about MMJ.

About CBi² Capital

Target Capital Inc., to be renamed CBi² Capital Corp. is a Calgary, Alberta based company engaged in making strategic investments in private companies, including small start‐up operations and land development corporations. CBi²'s common shares are listed on the TSX Venture Exchange and the Canadian Securities Exchange under the trading symbol "TCI". Target is executing on a cannabis-focused investment strategy, where it intends to develop and manage a diversified portfolio of predominantly early stage cannabis investment opportunities. Target will explore and invest in a number of strategic investment opportunities in the medical and recreational cannabis industry and in businesses offering ancillary supportive products and services. Upon receipt of shareholder approval, Target will change its name to "CBi² Capital Corp.".

Forward-Looking and Cautionary Statements

This news release may include forward-looking statements including opinions, assumptions, estimates, and, more particularly, statements concerning: CBi2's investment strategy and the ability to exercise thereon; and the Alliance, including information sharing, investment opportunities and an expanded business relationship between CBi2 and MMJ.

When used in this document, the words "will," "anticipate," "believe," "estimate," "expect," "intent," "may," "project," "should," and similar expressions are intended to be among the statements that identify forward-looking statements.

The forward-looking statements are founded on the basis of expectations and assumptions made by CBi2 which include, but are not limited to, the availability of suitable investment opportunities in the cannabis industry; the estimated growth in the cannabis market; shifts in public opinion regarding cannabis; market trends in the cannabis industry, the securities markets and the general economy; and the expected adult-use cannabis legalization in Canada.

Although CBi2 believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because CBi2 can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, risks associated with the cannabis industry in general; actions and initiatives of federal and provincial governments and changes to government policies and the execution and impact of these actions, initiatives and policies, including the fact that adult-use cannabis is currently illegal under federal and provincial law; the size of the medical-use and adult-use cannabis market; competition from other industry participants; and other factors more fully described from time to time in the reports and filings made by CBi2 with securities regulatory authorities.

The forward-looking information contained in this news release is made as of the date hereof and CBi2 undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, unless required by applicable securities laws. The forward looking information contained in this news release is expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE CBi2 Capital